Chain-of-thought monitorability could improve generative AI safety by assessing how models come to their conclusions and ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Google’s DeepMind and OpenAI, which makes ChatGPT, say they both achieved a gold medal-level performance at this year's ...

On the early evening of June 22, 2010, American tennis star John Isner began a grueling Wimbledon match against Frenchman ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...

Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.

After years of development, Murdoch says human clinical trials for Isomorphic’s AI-designed drugs are finally within reach.

Discover how AI models from Google and OpenAI outshined human brilliance at the 2025 IMO, and the ethical debates that ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.